Patient Corner

Anatomical Illustrations

More

Last reference updates

  • Nov 28, 2017 - MedWatch Drug Updates

Recall of Riomet (Metformin Hydrochloride Oral Solution) by Sun Pharmaceutical: Presence of microbial contamination

Sun Pharmaceutical initiated recall of Metformin Hydrochloride Oral Solution due to presence of microbial contamination which may cause respiratory tract infections

  • Dec 6, 2017 - MedWatch Drug Updates

Recall of pharmacist choice alcohol prep pads by simple diagnostics due to quality concerns.

Simple Diagnostics has recalled alcohol prep pads due to lack of sterility assurance and other quality issues.

  • Dec 4, 2017 - MedWatch Drug Updates

Fading print on label of AlbuRx 25, Albumin (Human) 25% solution

CSL Behring is addressing the print settings to ensure readability throughout the shelf life of the product.

  • Nov 29, 2017 - MedWatch Drug Updates

FDA safety alert: Biotin (Vitamin B7) interferes with certain lab tests

Interference of biotin with lab test can give false results leading to inappropriate patient management or misdiagnosis.

  • Nov 22, 2017 - MedWatch Drug Updates

FDA investigated life-threatening adverse events associated with Limbrel Capsules by Primus Pharmaceuticals

Drug-induced liver injury and hypersensitivity pneumonitis reported with use of Limbrel capsules.

  • Nov 21, 2017 - MedWatch Drug Updates

Recall of Diphenoxylate Hydrochloride and Atropine Sulfate by Greenstone: Sub-potent or super-potent product

Use of super potent or sub potent products may predispose patient to toxicity.

  • Sep 29, 2017 - MedWatch Drug Updates

FDA update: Type III endoleaks associated with the use of endovascular graft systems

FDA evaluates recent information regarding Type IIIa and IIIb endoleaks with the use of endovascular graft systems indicated for a endovascular aneurysm repair (EVAR)

  • Sep 28, 2017 - MedWatch Drug Updates

FDA update: High risk of mortality and neurological adverse events when using SynCardia's TAH-t C2 Driver System

Increased risk of mortality and neurological adverse events in patients using TSynCardia's TAH-t C2 Driver System.

  • Sep 28, 2017 - MedWatch Drug Updates

Class I Recall of Bridge Occlusion Balloon Catheter Model 590-001 by Spectranetics: Blocked guidewire lumen

Spectranetics has recalled Bridge Occlusion Balloon Catheter due to blockage of guidewire lumen which may results in serious adverse events.

  • Nov 16, 2017 - MedWatch Drug Updates

Recall of Nexterone (amiodarone HCl) 150 mg/100 mL premixed injection by Baxter- Presence of particulate matter

Presence of particulate matter in solution for intravenous administration may lead to adverse health consequences.